Tuesday, September 15, 2026

K-Beauty to drive global growth through convergence with biotech and fashion, KHIDI official says [Moon Dae-hyun’s MediView]

K-beauty aims for growth by integrating with biotech, medical devices, and fashion, enhancing global competitiveness and sustainability.

President Lee Proposes Humanitarian Exchange With North Korea Ahead of Separated Family Day

President Lee proposes humanitarian exchanges for separated families amid a seven-year hiatus in reunions, reflecting deep concerns over aging relatives.

IVE’s North American Tour Kicks Off: What Fans Can Expect from SHOW WHAT I AM

IVE kicked off their North American tour with electrifying performances in Canada, thrilling fans with new styles and powerful shows.

Health

Celltrion Submits U.S. Phase 4 IND for High-Dose 240 mg Zymfentra

Celltrion has submitted a U.S. Phase 4 trial application to support the use of a higher 240 mg dose of Zymfentra, aiming to expand personalized dosing options and strengthen the drug's position in the U.S. market.

Blood Proteins May Offer Clues to Alzheimer’s Antibody Treatment Benefits and Side-Effect Risks

A South Korean study found that blood levels of complement proteins C1q and C3 may help predict amyloid reduction and ARIA risk in patients receiving lecanemab, though larger studies are needed.

Pentrym Confirms Combination Benefits With Existing Cancer Drugs, Targets “False Resistance”

Pentrym is testing whether targeting the tumor microenvironment alongside existing cancer drugs can overcome “false resistance” and improve treatment effectiveness.

YH42946: The Promising HER2 Targeted Oral Treatment Set to Transform Cancer Care in 2026

Yuhan Corporation will reveal early results of its oral HER2-targeted therapy candidate 'YH42946' in clinical trials by year-end.

SK Biopharm Achieves MSCI ESG AAA Rating for 3rd Consecutive Year: What It Means for the Pharma Industry

SK Biopharm has achieved the highest AAA rating in MSCI's ESG evaluation for three consecutive years.
Latest

Unlocking NABOTA®: How Daewoong Pharmaceutical is Elevating Global Botulinum Toxin Expertise

Daewoong Pharmaceutical held the NABOTA®EDGE: Global Academic Program for 40 key personnel from 22 global partners in Jeju.

How Medical Accident Disclosure Could Transform Patient Rights in South Korea

A patient with spinal surgery suffered paralysis due to a medical accident, raising concerns about informed consent in healthcare.

Flu and COVID-19 Surge: What Asian Parents Need to Know for Fall 2026

The rise of influenza and COVID-19 raises concerns about respiratory infections this fall.

Why Quitting Smoking After Cancer Diagnosis is Crucial: Study Reveals 36% Lower Heart Disease Risk

A study shows cancer patients who continue smoking face higher risks of cardiovascular disease and death compared to those who quit.

Roche’s HM17321: The Revolutionary Obesity Drug Transforming Weight Loss and Muscle Preservation

Roche focuses on Hanmi Pharmaceutical's obesity drug candidate HM17321 due to promising preclinical results for weight loss and muscle preservation.

Revolutionary Single-Port Robotic Surgery for Pediatric Choledochal Cyst: A 22-Month-Old’s Journey

A pediatric surgery team successfully performed single-port robotic surgery on a 22-month-old child, showcasing advanced techniques.

GPT-6 Astra vs GPT-5.6: How OpenAI’s New Model Outperforms in Speed and Intelligence

OpenAI announces the launch of its next-gen AI model, GPT-6 Astra, marking the beginning of artificial general intelligence (AGI).

Discover the Everyone’s AI Revolution: How Kakao and Partners Are Transforming Daily Life with Free AI Services

Kakao, SK Telecom, and KT are set to launch a universal chatbot service for free public use as part of the government's Everyone's AI initiative.

Revolutionary AI Unveils Color Change Mechanism in OLED and Fluorescent Materials

A research team developed AI technology explaining color and brightness changes in new materials, aiding OLEDs, fluorescent substances, and solar cells.

Hanmi Pharmaceutical to Present Phase 2 Clinical Results for Congenital Hyperinsulinism Treatment at European Conference

Hanmi Pharmaceutical will present Phase 2 data on its investigational treatment efpeglenatide (HM15136) for congenital hyperinsulinism at the 64th European Society for Paediatric Endocrinology meeting in France.

“It’s Not Just a Women’s Issue”: Men Also Face Osteoporosis Risk With Age-Related Hormone Decline

Men with low testosterone and vitamin D levels face a significantly higher risk of reduced hip bone density, a study found.

Skylabs Lists on KOSDAQ, Aiming to Become Global Medical Data Platform

Skylabs has listed on the KOSDAQ market, accelerating its global expansion while broadening its business from blood pressure monitoring to multivital monitoring and medical data.

Curocell’s ‘Lymcato’ Clears Review for National Health Insurance Coverage

Curocell’s CAR-T therapy Lymcato has passed the Health Insurance Review and Assessment Service’s drug reimbursement review, accelerating its path toward national health insurance coverage this year.

Why Severance Hospital Dominates the Korean Wellness Index for 20 Consecutive Years?

Severance Hospital has ranked first in the Korean Wellness Index for hospitals for 20 consecutive years, showcasing its excellence.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.